The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

Blog
GP with stethescope around his neck faces a computer
Monday 12 February 2018
On Saturday, 10 February 2018 I had the pleasure of attended Medical Students’ Day hosted by the Royal College of Obstetricians and Gynaecologists (RCOG) and British Undergraduate Society for Obstetrics and Gynaecology (BUSOG). An annual event in the RCOG/BUSOG calendar, but a first for Target...
News
researcher looking at agar plates
Thursday 25 January 2018
Target Ovarian Cancer is delighted to announce a new call for research project grant applications, as part of our distinctive medical research programme. We are inviting researchers from across the UK to apply for up to £200,000 of funding for projects that aim to optimise and develop more...
News
Doctor at desk
Friday 19 January 2018
There has been a lot of coverage in the news today of a new test being developed in the United States that aims to detect eight different cancers (ovary, liver, stomach, pancreas, oesophagus, bowel, lung and breast) earlier.1 This test aims to combine checking for tumour DNA and certain types of...
News
Two nurses discuss treatment for their patient
Monday 18 December 2017
New ovarian cancer drug niraparib (Zejula ®), which was licensed for use in the UK by the European Medicines Agency last month, is part of a new class of ovarian cancer drugs called PARP inhibitors. Niraparib is yet to be approved for availability on the NHS; a decision is expected in the new year...

Pages